Search research articles
Contact Us
Filters
Showing results (11-20 of 170) with videos related to
Page
of 17
Sort By:
The Lancet. Infectious Diseases
|
November 21, 2009
Tuberculosis and diabetes mellitus: convergence of two epidemics
Kelly E Dooley, Richard E Chaisson
Clinics in Chest Medicine
|
November 17, 2019
New Drugs for the Treatment of Tuberculosis
Elisa H Ignatius, Kelly E Dooley
Microbiology Spectrum
|
February 25, 2017
Tuberculosis Associated with HIV Infection
Jeffrey A Tornheim, Kelly E Dooley
The Journal of Infectious Diseases
|
August 21, 2008
Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries
Kelly E Dooley, Charles Flexner, Adriana S Andrade
The Lancet. HIV
|
February 5, 2022
Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps
Anushka Naidoo, Kogieleum Naidoo, Nesri Padayatchi, et al.
The New England Journal of Medicine
|
April 4, 2019
Pharmacologic Research in Pregnant Women - Time to Get It Right
Ahizechukwu C Eke, Kelly E Dooley, Jeanne S Sheffield
Current Opinion in HIV and AIDS
|
October 9, 2013
Pipeline of drugs for related diseases: tuberculosis
Kelly E Dooley, Eric L Nuermberger, Andreas H Diacon
Antimicrobial Agents and Chemotherapy
|
August 13, 2014
Impact of lopinavir-ritonavir or nevirapine on bedaquiline exposures and potential implications for patients with tuberculosis-HIV coinfection
Elin M Svensson, Kelly E Dooley, Mats O Karlsson
Seminars in Neurology
|
May 24, 2018
The Global Neurological Burden of Tuberculosis
Kiran Thakur, Mitashee Das, Kelly E Dooley, et al.
Future Microbiology
|
June 5, 2010
TMC207: the first compound of a new class of potent anti-tuberculosis drugs
Alberto Matteelli, Anna Cc Carvalho, Kelly E Dooley, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 170) with videos related to
Sort By:
Page
of 17
The Lancet. Infectious Diseases
|
November 21, 2009
Tuberculosis and diabetes mellitus: convergence of two epidemics
Kelly E Dooley, Richard E Chaisson
Clinics in Chest Medicine
|
November 17, 2019
New Drugs for the Treatment of Tuberculosis
Elisa H Ignatius, Kelly E Dooley
Microbiology Spectrum
|
February 25, 2017
Tuberculosis Associated with HIV Infection
Jeffrey A Tornheim, Kelly E Dooley
The Journal of Infectious Diseases
|
August 21, 2008
Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries
Kelly E Dooley, Charles Flexner, Adriana S Andrade
The Lancet. HIV
|
February 5, 2022
Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps
Anushka Naidoo, Kogieleum Naidoo, Nesri Padayatchi, et al.
The New England Journal of Medicine
|
April 4, 2019
Pharmacologic Research in Pregnant Women - Time to Get It Right
Ahizechukwu C Eke, Kelly E Dooley, Jeanne S Sheffield
Current Opinion in HIV and AIDS
|
October 9, 2013
Pipeline of drugs for related diseases: tuberculosis
Kelly E Dooley, Eric L Nuermberger, Andreas H Diacon
Antimicrobial Agents and Chemotherapy
|
August 13, 2014
Impact of lopinavir-ritonavir or nevirapine on bedaquiline exposures and potential implications for patients with tuberculosis-HIV coinfection
Elin M Svensson, Kelly E Dooley, Mats O Karlsson
Seminars in Neurology
|
May 24, 2018
The Global Neurological Burden of Tuberculosis
Kiran Thakur, Mitashee Das, Kelly E Dooley, et al.
Future Microbiology
|
June 5, 2010
TMC207: the first compound of a new class of potent anti-tuberculosis drugs
Alberto Matteelli, Anna Cc Carvalho, Kelly E Dooley, et al.
Page
of 17